Active specific immunotherapy using attenuated autologous tumor cells in malignant melanoma (2000)
- Authors:
- Autor USP: BRENTANI, MARIA MITZI - FM
- Unidade: FM
- Assunto: RADIOLOGIA
- Language: Inglês
- Imprenta:
- Conference titles: An International Symposium Sponsored by the Cancer Research Institute
-
ABNT
SILVA, Debora C. P. et al. Active specific immunotherapy using attenuated autologous tumor cells in malignant melanoma. 2000, Anais.. New York: Faculdade de Medicina, Universidade de São Paulo, 2000. . Acesso em: 03 jun. 2024. -
APA
Silva, D. C. P., Feher, O., Gross, J., Neves, R. I., & Brentani, M. M. (2000). Active specific immunotherapy using attenuated autologous tumor cells in malignant melanoma. In . New York: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Silva DCP, Feher O, Gross J, Neves RI, Brentani MM. Active specific immunotherapy using attenuated autologous tumor cells in malignant melanoma. 2000 ;[citado 2024 jun. 03 ] -
Vancouver
Silva DCP, Feher O, Gross J, Neves RI, Brentani MM. Active specific immunotherapy using attenuated autologous tumor cells in malignant melanoma. 2000 ;[citado 2024 jun. 03 ] - Caracterizacao de receptor de estrogeno tipo ii em celulas mcf-7
- Histopathological parameters as prognostic factors in female breast cancer patients
- Limphocytic infiltration as a prognostic factor in breast cancer
- Marcadores tumorais: importancia na determinacao dos receptores de estrogeno e progesterona
- Presence of two types of estrogen binding sites in human breast cancer
- Importancia da dosagem de receptor para orientacao da terapeutica clinica do cancer de mama
- Effects of steroids on growth and laminin receptors in a human melanoma cells (mel-85)
- Prognostic value of plasminogen activator in breast cancer
- Bases da oncologia
- Galectin-3 is a modulator of fibroblast migration towards laminin-1
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas